| 1 |
Use of SGLT2 inhibitors during Ramadan: An expert panel statement |
|
| | Mohamed Hassanein,Alaaeldeen Bashier,Hoosen Randeree,Megahed Abouelmagd,Waleed AlBaker,Bachar Afandi,Omar Abu Hijleh,Inass Shaltout,Magdy EI-Sharkawy,Selcuk Dagdelen,Samir Assaad Khalil | | | Diabetes Research and Clinical Practice. 2020; 169: 108465 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Evolving physicians’ perceptions and practices regarding use of SGLT2 inhibitors for type 2 diabetes during Ramadan fasting |
|
| | Salem A. Beshyah,Khadija Hafidh,Tariq Gul Shaikh | | | Diabetes Research and Clinical Practice. 2020; 168: 108389 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Effectiveness and Safety of Newer Antidiabetic Medications for Ramadan Fasting Diabetic Patients |
|
| | Ehab Mudher Mikhael | | | Journal of Diabetes Research. 2016; 2016: 1 | | | [Pubmed] [Google Scholar] [DOI] | |
|
